2017 SMC Implementation Meeting
February 13-15th 2017
SMC has the potential to reduce malaria mortality by 75 percent in areas with high seasonal transmission, providing a high degree of protection against malaria for eligible children under five years of age.
ACCESS-SMC was the leader in catalyzing the scale-up of access to SMC. During the first campaign in 2015, the project procured and administered over 12 million treatments of SMC to over 3.1 million children. In 2016, this number more than doubled to approximately 25 million treatments being administered to over 6.3 million children during the second campaign. Approximately 80 percent of the SMC medicines delivered by the project were in a new dispersible, sweetened child-friendly formulation, which was easier to administer and more palatable to children. The project helped train over 50,000 health workers and volunteers, strengthening health systems and pharmacovigilance. SMC was confirmed to be extremely safe, with less than 0.001% of all treated children in ACCESS-SMC countries showing signs of severe adverse reactions, and no fatalities recorded.
Evidence from the 2015 costing study estimated the average cost per child to receive SMC each year is just $4.27, making this a relatively low-cost intervention in relation to its impact. Though nearly 70 million treatments were procured in 2016 for all eligible Sahelian countries, reducing the gap, over 100 million treatments are needed to reach all eligible children.
ACCESS-SMC's goal is not only to prevent malaria among children under the age of five for the duration of the project, but to mobilize donors and host governments to commit to sustaining and scaling up SMC to ensure that the 25 million eligible children receive this treatment. Achieving universal coverage of SMC requires joint efforts, innovative approaches, such as the integration of other public health interventions with the SMC platform, and sustained funding.
Event and Objectives
There has been an increasing amount of interest in the SMC intervention from governments, donors and stakeholders. As a result, Malaria Consortium in collaboration with the WHO Global Malaria Program (GMP), the West Africa Health Organization (WAHO), and the ACCESS-SMC partner organizations, organized a three-day seminar to share key lessons learned and recommendations for future implementations of SMC beyond the ACCESS-SMC project, which ends February 2018.
More than 90 participants from 12 NMCPs and 24 implementing partners attended this three-day meeting, including partners invested in funding SMC, such as UNITAID, Global Fund, UNICEF and the President’s Malaria Initiative (PMI). During the first day of the seminar twelve NMCP representatives shared their experiences, lessons learned and the current status of their SMC campaign efforts. The second day, countries provided updated information on QA, safety and M&E. Everyone was then split in two twelve groups to reflect on plans and gaps that needed to be addressed to ensure the success of the 2017 and 2018 campaigns. On the final day, steps and procedures were defined for NMCPs to follow to ensure a smooth transition from project to program.
- To ensure the effective scale up and sustainability in SMC eligible countries
- To share updates and lessons learned from the 2015 and 2016 campaigns
- To discuss methods and lessons for measuring programmatic outcome and safety of SMC
- To identify priorities and gaps in plans for the implementation of SMC in 2017 and 2018
- To develop a long-term country-led scale-up and operational sustainability plan for SMC
This event placed SMC within a broader discussion about health system strengthening and health investments. The possibility of integrating SMC into national malaria control and elimination strategies plans using regional collaboration frameworks accompanied by sustained monitoring research, funding and global partnerships was also examined.
This event hosted people from various sectors, most notably NGOs, multilateral donors and agencies, academic institutions, private companies and foundations, as well as the public sector including Ministry of Health representatives from supported countries.
Click here to find the presentations made at the symposium.
Didn't make it to the symposium? Read the post event report here